Characterization of Antibody Responses to Virus Infections in Humans
This book focuses on fundamental and applied research on humoral immune responses to viral infections in humans. The comprehensive study of antibody response is critical for the development of diagnostic tools, vaccines, and immunotherapeutics against life-threatening viral infections. Special atten...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_87440 | ||
| 005 | 20220706 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220706s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-4368-0 | ||
| 020 | |a 9783036543673 | ||
| 020 | |a 9783036543680 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-4368-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Ilinykh, Philipp |4 edt | |
| 700 | 1 | |a Huang, Kai |4 edt | |
| 700 | 1 | |a Ilinykh, Philipp |4 oth | |
| 700 | 1 | |a Huang, Kai |4 oth | |
| 245 | 1 | 0 | |a Characterization of Antibody Responses to Virus Infections in Humans |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (142 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book focuses on fundamental and applied research on humoral immune responses to viral infections in humans. The comprehensive study of antibody response is critical for the development of diagnostic tools, vaccines, and immunotherapeutics against life-threatening viral infections. Special attention is given to serological surveillance and characterization of virus-neutralizing antibodies. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a highly pathogenic avian influenza virus | ||
| 653 | |a H5N6 (clade 2.3.4.4) | ||
| 653 | |a human sera | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a COVID-19 | ||
| 653 | |a full proteome | ||
| 653 | |a peptide microarrays | ||
| 653 | |a glycan microarrays | ||
| 653 | |a seroprevalence | ||
| 653 | |a ELISA | ||
| 653 | |a neutralization assay | ||
| 653 | |a viral persistence | ||
| 653 | |a serum antibody | ||
| 653 | |a neutralization efficacy | ||
| 653 | |a cytokine profile | ||
| 653 | |a neutralising antibodies | ||
| 653 | |a filoviruses | ||
| 653 | |a ebolavirus | ||
| 653 | |a post-vaccination | ||
| 653 | |a post-infection | ||
| 653 | |a monoclonal antibodies | ||
| 653 | |a longitudinal antibody response | ||
| 653 | |a antibody specificity | ||
| 653 | |a recombinant proteins | ||
| 653 | |a virus neutralization | ||
| 653 | |a coronavirus disease 2019 | ||
| 653 | |a Guangdong | ||
| 653 | |a China | ||
| 653 | |a antibody | ||
| 653 | |a varicella-zoster virus (VZV) | ||
| 653 | |a chemiluminescent immunoassay (CLIA) | ||
| 653 | |a IgA | ||
| 653 | |a IgG | ||
| 653 | |a IgM | ||
| 653 | |a diagnostic test | ||
| 653 | |a antibody therapeutic | ||
| 653 | |a cryo-EM | ||
| 653 | |a filovirus | ||
| 653 | |a marburgvirus | ||
| 653 | |a structural biology | ||
| 653 | |a X-ray crystallography | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5628 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/87440 |7 0 |z DOAB: description of the publication |